Pacer Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Sell |
23,643
-913,713
| -97% | -$53.3M | ﹤0.01% | 1096 |
|
|
2025
Q4 | $55.7M | Buy |
937,356
+327,204
| +54% | +$17.8M | 0.15% | 162 |
|
|
2025
Q3 | $33M | Buy |
610,152
+604,439
| +10,580% | +$34.6M | 0.08% | 229 |
|
|
2025
Q2 | $314K | Sell |
5,713
-623
| -10% | -$36.7K | ﹤0.01% | 1588 |
|
|
2025
Q1 | $448K | Sell |
6,336
-31,087
| -83% | -$2.09M | ﹤0.01% | 1502 |
|
|
2024
Q4 | $2.46M | Buy |
37,423
+1,938
| +5% | +$130K | 0.01% | 887 |
|
|
2024
Q3 | $2.49M | Sell |
35,485
-1,847
| -5% | -$154K | 0.01% | 875 |
|
|
2024
Q2 | $3.07M | Buy |
37,332
+36,829
| +7,322% | +$3.07M | 0.01% | 762 |
|
|
2024
Q1 | $43.9K | Buy |
+503
| New | +$45K | ﹤0.01% | 3219 |
|
|
2021
Q2 | – | Sell |
-1,019
| Closed | -$77K | – | 1428 |
|
|
2021
Q1 | $77K | Sell |
1,019
-646
| -39% | -$52.8K | ﹤0.01% | 1330 |
|
|
2020
Q4 | $146K | Sell |
1,665
-11,832
| -88% | -$938K | ﹤0.01% | 1287 |
|
|
2020
Q3 | $1.03M | Sell |
13,497
-709
| -5% | -$71.7K | 0.02% | 692 |
|
|
2020
Q2 | $1.75M | Sell |
14,206
-370
| -3% | -$36.8K | 0.04% | 411 |
|
|
2020
Q1 | $1.3M | Buy |
14,576
+1,208
| +9% | +$104K | 0.03% | 212 |
|
|
2019
Q4 | $1.13M | Buy |
13,368
+1,453
| +12% | +$110K | 0.05% | 512 |
|
|
2019
Q3 | $803K | Buy |
11,915
+814
| +7% | +$62.7K | 0.02% | 887 |
|
|
2019
Q2 | $951K | Buy |
11,101
+1,127
| +11% | +$96.4K | 0.02% | 823 |
|
|
2019
Q1 | $886K | Buy |
+9,974
| New | +$924K | 0.02% | 483 |
|
|
2018
Q4 | – | Sell |
-9,180
| Closed | -$890K | – | 594 |
|
|
2018
Q3 | $890K | Buy |
9,180
+3,528
| +62% | +$352K | 0.03% | 690 |
|
|
2018
Q2 | $532K | Buy |
5,652
+1,048
| +23% | +$91.8K | 0.02% | 891 |
|
|
2018
Q1 | $373K | Sell |
4,604
-44
| -0.9% | -$3.78K | 0.02% | 826 |
|
|
2017
Q4 | $414K | Sell |
4,648
-1,418
| -23% | -$123K | 0.03% | 767 |
|
|
2017
Q3 | $565K | Buy |
6,066
+744
| +14% | +$65.7K | 0.05% | 605 |
|
|
2017
Q2 | $483K | Buy |
5,322
+687
| +15% | +$62.5K | 0.05% | 622 |
|
|
2017
Q1 | $407K | Buy |
4,635
+193
| +4% | +$17.2K | 0.05% | 610 |
|
|
2016
Q4 | $368K | Sell |
4,442
-86
| -2% | -$7.4K | 0.05% | 564 |
|
|
2016
Q3 | $419K | Buy |
4,528
+189
| +4% | +$17.8K | 0.06% | 441 |
|
|
2016
Q2 | $338K | Buy |
4,339
+52
| +1% | +$4.42K | 0.05% | 512 |
|
|
2016
Q1 | $353K | Buy |
4,287
+109
| +3% | +$8.87K | 0.08% | 261 |
|
|
2015
Q4 | $437K | Buy |
+4,178
| New | +$436K | 0.1% | 201 |
|
Other funds holding BMRN
VCM
VPM
